{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:15:36Z","timestamp":1724544936212},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.rmr.2024.06.004","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T21:12:01Z","timestamp":1719349921000},"page":"455-462","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adh\u00e9sion \u00e0 la kin\u00e9sith\u00e9rapie respiratoire chez les adultes atteints de mucoviscidose"],"prefix":"10.1016","volume":"41","author":[{"given":"T.","family":"Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Reychler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sorlat-Maire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Perceval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Nove-Josserand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2024.06.004_bib0170","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.298.15.1787","article-title":"Adult cystic fibrosis","volume":"298","author":"Boyle","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.rmr.2024.06.004_bib0175","unstructured":"Vaincre la Mucoviscidose. Registre Fran\u00e7ais de La Mucoviscidose. 2018."},{"key":"10.1016\/j.rmr.2024.06.004_bib0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jcf.2008.09.007","article-title":"High treatment burden in adults with cystic fibrosis: challenges to disease self-management","volume":"8","author":"Sawicki","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2024.06.004_bib0185","doi-asserted-by":"crossref","first-page":"e13350","DOI":"10.1111\/ijcp.13350","article-title":"Prevalence of and factors associated with primary medication non-adherence in chronic disease: a systematic review and meta-analysis","volume":"73","author":"Cheen","year":"2019","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.rmr.2024.06.004_bib0190","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thx.49.2.115","article-title":"Treatment compliance in adults with cystic fibrosis","volume":"49","author":"Abbott","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2024.06.004_bib0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.51.1.29","article-title":"Compliance with treatment in adult patients with cystic fibrosis","volume":"51","author":"Conway","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2024.06.004_bib0200","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/1359105306069093","article-title":"Adherence to chest physiotherapy in adults with cystic fibrosis","volume":"11","author":"Myers","year":"2006","journal-title":"J Health Psychol"},{"key":"10.1016\/j.rmr.2024.06.004_bib0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4187\/respcare.01389","article-title":"Adherence to airway clearance therapies by adult cystic fibrosis patients","volume":"58","author":"Flores","year":"2013","journal-title":"Respir Care"},{"key":"10.1016\/j.rmr.2024.06.004_bib0210","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcf.2008.01.003","article-title":"Treatment compliance in children and adults with cystic fibrosis","volume":"7","author":"Arias Llorente","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2024.06.004_bib0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ppul.23017","article-title":"Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives","volume":"50","author":"Sawicki","year":"2015","journal-title":"Pediatr Pulmonol"},{"year":"2017","series-title":"Protocole National de Diagnostic et de Soins (PNDS) Mucoviscidose","key":"10.1016\/j.rmr.2024.06.004_bib0220"},{"key":"10.1016\/j.rmr.2024.06.004_bib0225","first-page":"CD011231","article-title":"Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews","volume":"1","author":"Wilson","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2024.06.004_bib0230","doi-asserted-by":"crossref","first-page":"250S","DOI":"10.1378\/chest.129.1_suppl.250S","article-title":"Non-pharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines","volume":"129","author":"McCool","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2024.06.004_bib0235","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.4187\/respcare.02990","article-title":"Adherence of subjects with cystic fibrosis to their home program: a systematic review","volume":"59","author":"O\u2019Donohoe","year":"2014","journal-title":"Respir Care"},{"key":"10.1016\/j.rmr.2024.06.004_bib0240","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ppul.23317","article-title":"Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes","volume":"50","author":"Oates","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.rmr.2024.06.004_bib0245","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thorax.57.5.459","article-title":"Determinants of adherence in adults with cystic fibrosis","volume":"57","author":"Kettler","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2024.06.004_bib0250","first-page":"Doc16","article-title":"50\u00a0% adherence of patients suffering chronic conditions \u2013 where is the evidence?","volume":"10","author":"Mathes","year":"2012","journal-title":"GMS Ger Med Sci"},{"key":"10.1016\/j.rmr.2024.06.004_bib0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hcz058","article-title":"Medication adherence among patients with chronic diseases: a survey-based study in pharmacies","volume":"112","author":"J\u00fcngst","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.rmr.2024.06.004_bib0260","doi-asserted-by":"crossref","first-page":"217047","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.rmr.2024.06.004_bib0265","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.dsx.2020.06.042","article-title":"Impact of COVID-19\u00a0on routine care for chronic diseases: a global survey of views from healthcare professionals","volume":"14","author":"Chudasama","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.rmr.2024.06.004_bib0270","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4187\/respcare.06500","article-title":"Persistent adherence to airway clearance therapy in adults with cystic fibrosis","volume":"64","author":"Sherman","year":"2019","journal-title":"Respir Care"},{"key":"10.1016\/j.rmr.2024.06.004_bib0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/17476348.2017.1280399","article-title":"Adherence to therapies in cystic fibrosis: a targeted literature review","volume":"11","author":"Narayanan","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.rmr.2024.06.004_bib0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/2049-3258-72-37","article-title":"Adherence influencing factors - a systematic review of systematic reviews","volume":"72","author":"Mathes","year":"2014","journal-title":"Arch Public Health"},{"key":"10.1016\/j.rmr.2024.06.004_bib0285","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.arcped.2012.04.010","article-title":"L\u2019adh\u00e9sion th\u00e9rapeutique chez l\u2019adolescent atteint de maladie chronique\u00a0: \u00e9tat de la question Compliance among adolescents with a chronic illness: review","volume":"19","author":"Bouteyre","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.rmr.2024.06.004_bib0290","first-page":"2","article-title":"Understanding non-compliance with treatment in adults with cystic fibrosis","volume":"93","author":"Dodd","year":"2000","journal-title":"J R Soc Med"},{"key":"10.1016\/j.rmr.2024.06.004_bib0295","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jadohealth.2004.09.013","article-title":"Adherence to treatment in children and adolescent patients with cystic fibrosis","volume":"38","author":"Zindani","year":"2006","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.rmr.2024.06.004_bib0300","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jcf.2019.03.003","article-title":"Physical activity and associations with clinical outcome measures in adults with cystic fibrosis; a systematic review","volume":"18","author":"Shelley","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.rmr.2024.06.004_bib0305","first-page":"CD002768","article-title":"Physical exercise training for cystic fibrosis","volume":"11","author":"Radtke","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmr.2024.06.004_bib0310","doi-asserted-by":"crossref","first-page":"1801793","DOI":"10.1183\/13993003.01793-2018","article-title":"Effects of exercise and airway clearance (positive expiratory pressure) on mucus clearance in cystic fibrosis: a randomised crossover trial","volume":"53","author":"Dwyer","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2024.06.004_bib0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13643-019-1014-8","article-title":"Medication adherence influencing factors-an (updated) overview of systematic reviews","volume":"8","author":"Gast","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.rmr.2024.06.004_bib0320","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3121\/cmr.2013.1113","article-title":"Patient characteristics associated with medication adherence","volume":"11","author":"Rolnick","year":"2013","journal-title":"Clin Med Res"},{"key":"10.1016\/j.rmr.2024.06.004_bib0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/rccm.202011-4153OC","article-title":"Rapid improvement after starting elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis and advanced pulmonary disease","volume":"204","author":"Burgel","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2024.06.004_bib0165","first-page":"100829","article-title":"Patient perspectives following initiation of elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis and advanced lung disease","volume":"80","author":"Martin","year":"2021","journal-title":"Respir Med Res"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842524002304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842524002304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T03:33:57Z","timestamp":1724470437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842524002304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0761842524002304"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2024.06.004","relation":{},"ISSN":["0761-8425"],"issn-type":[{"type":"print","value":"0761-8425"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adh\u00e9sion \u00e0 la kin\u00e9sith\u00e9rapie respiratoire chez les adultes atteints de mucoviscidose","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2024.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 SPLF. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}